Antiviral therapy for HIV virus: 15-Deoxy-Δ12,14 Prostaglandin J2 (15d-PGJ2) increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 21/April/2017, 4.03 pm

Natural product-derived PD-1 pathway blockade for Human cancer therapy: Nectandrin B, isolated from Nutmeg, decreases the activity of Glycogen synthase kinase-3β, increases transcription factor T-bet expression, decreases the abundance of co-inhibitory receptor PD-1 on the cell surface of Cytotoxic-T-cells, increases cytotoxic T lymphocyte function and augments anti-tumor activity, via up-regulation of its target gene, 21/April/2017, 6.21 am
April 21, 2017
Natural product-derived PD-L1 pathway blockade enhances the efficacy of Cancer immunotherapy: Marrubium vulgare extract inhibits the expression of PD-L1, inhibits inflammatory signalling and the number of tumor-infiltrating lymphocytes and macrophages, increases Cytotoxic activity of T-cells, decreases tumor burden and increases survival via up-regulation of its target gene, 21/April/2017, 10.15 pm
April 21, 2017
Show all

What we say:

Dr L Boominathan PhD, Director-Price 100cum-chief Scientist of GBMD, reports that: Antiviral therapy for HIV virus: 15-Deoxy-Δ12,14 Prostaglandin J2 (15d-PGJ2) increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene


From Significance of the study to Public health relevance:

Given that: (1) more than 37 million people worldwide are living with HIV/AIDS; (2) there is no effective vaccine available for HIV/AIDS; (3) HIV/AIDS tops the list of incurable diseases in humans; (4) the life-long painful drug treatment is required to treat HIV/AIDS and its associated opportunistic infections; (5) the global economic cost spent for HIV treatment is enormous, there is an urgent need to find: (i) a way to restore CD4 T-cells that were lost in HIV/AIDS; (ii) a cheaper alternative to the existing expensive antiviral drugs; (iii) a side-effect-free natural product-based drug; and (iv) a way to cure, not just treat, HIV-1/AIDS.


From Research findings to Therapeutic opportunity:

This study suggests, for the first time, a small molecule-based antiviral therapy against RNA viruses such as HIV-1.

15-Deoxy-Δ12,14 Prostaglandin J2 (15d-PGJ2), by increasing the expression of its target gene, it may increase the expression of Heme oxygenase-2 (HO-2) (Figure 1). Thereby, it may: (1) bind and block the myristate moiety of HIV-1 Gag protein; (2) disrupt HIV-1 budding; (3) restrict HIV-1 infectivity, replication and production; (4) promote clearance of HIV-1 and MLV virions; and (5) strengthen antiviral immunity against RNA viruses.

15-Deoxy-Δ12,14 Prostaglandin J2 (15d-PGJ2) induces HO2 and inhibits HIV1 replication

Figure 1 Mechanistic insights into how 15-Deoxy-Δ12,14 Prostaglandin J2 (15d-PGJ2) functions as an anti-HIV agent. 15d-PGJ2 inhibits HIV-1 budding and production via up-regulation of HO-2

Thus, pharmacological formulations encompassing 15-Deoxy-Δ12,14 Prostaglandin J2 (15d-PGJ2)  or its analogs either alone or in combination with other drugs” may be used to inhibit HIV-1 production.


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How does 15-Deoxy-Δ12,14 Prostaglandin J2 (15d-PGJ2)  increase the expression of Heme oxygenase-2 (HO-2)?

Amount: $100#

For payment and purchase details, you may reach us at admin@genomediscovery.org

# Research cooperation


References:

Web: http://genomediscovery.org or http://newbioideas.com/

Citation: Boominathan, L.,  Antiviral therapy for HIV virus: 15-Deoxy-Δ12,14 Prostaglandin J2 (15d-PGJ2) increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 21/April/2017, 4.03 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite, drop us a line at admin@genomediscovery.org

Comments are closed.